Skip to main content

The Mouse Version

Some cancer patients are paying for their own mouse avatars on which to test possible drug therapies, the Associated Press reports.

"What I'm doing is personalized cancer treatment. It's the wave of the future," breast cancer patient Eileen Youtie tells the AP. "Part of this is trying to eliminate chemos that are not going to work on me. I don't want to waste time taking them and poison my body."

By grafting a portion of their tumor into lab mice, patients like Youtie hope to learn what drugs will best target their particular cancer. For some patients, the AP notes that mouse avatar testing can reveal that a tumor appears to be sensitive to a drug that isn't typically used to treat that cancer type.

Still, the AP notes that such testing is experimental and may not provide more information than gene tests or better outcomes than standard therapies. Mouse avatar testing, it adds, can cost upwards of $10,000 and isn't typically covered by insurance.

"I do see promise, but it's very time-consuming, it's very expensive," says Oklahoma Medical Research Foundation's Alana Welm. "For the average patient, standard care is going to be the way to go."


The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.